====== Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) ======

{{ ::29dce7bcceddea25d429490fda87008d.png?200|}}

On April 17, 2020, the [[National Institutes of Health]] (NIH) announced the [[Accelerating COVID-19 Therapeutic Interventions and Vaccines]] (ACTIV) [[public-private partnership]] to develop a coordinated research strategy for prioritizing and speeding up development of [[COVID-19 vaccines]] and [[pharmaceutical products]].((//ACTIV.// National Institutes of Health (NIH). Retrieved April 1, 2022, from https://archive.ph/8eMTV)) 

ACTIV is a collaboration with the [[Foundation for the National Institutes of Health]] (FNIH), [[Biomedical Advanced Research and Development Authority]] (BARDA), [[center for disease control and prevention|Centers for Disease Control and Prevention]] (CDC), the U.S. [[Food and Drug Administration]] (FDA), the [[US Department of Defense]] (DOD), the [[Department of Veterans Affairs]] (VA), [[Countermeasures Acceleration Group]] (formerly [[Operation Warp Speed]]), and the [[European Medicines Agency]] (EMA).

===== Membership =====

==== ACTIV Executive Committee ====

The ACTIV Executive Committee is made up of representatives from various agencies of the U.S. government and [[pharmaceutical companies]].((//ACTIV Public-Private Partnership.// (2022). National Institutes of Health. https://web.archive.org/web/20220402051949/https://www.nih.gov/sites/default/files/research-training/initiatives/activ/activ-org-chart_3.2.22.pdf))

^ Name  ^ Organization  ^ Role  ^
| [[Larry Tabak]]  | [[National Institutes of Health]] (NIH) | Co-Chair  |
| [[William Pao]]  | [[pharmaceutical_companies:Roche]]  | Co-Chair  |
| [[Gary Disbrow]]  | [[BARDA]]  | Member  |
| [[Mikael Dolsten]]  | [[pharmaceutical_companies:Pfizer]]  | Member  |
| [[Anthony Fauci]]  | [[National Institutes of Health]] (NIH)  | Member  |
| [[Gary Gibbons]]  | [[National Institutes of Health]] (NIH)  | Member  |
| [[Peter Marks]]  | [[Food and Drug Administration]] (FDA)  | Member  |
| [[Gary Dubin]]  | [[pharmaceutical_companies:Takeda]]  | Member  |
| [[Janet Woodcock]]  | [[Food and Drug Administration]] (FDA)  | Member  |

==== Preclinical Working Group ====

^ Name  ^ Organization  ^ Role  ^
| [[Peter Adams]]((//Preclinical Working Group.// (2022, March 8). National Institutes of Health (NIH). https://archive.ph/dvDVw))  | [[Department of Health of Human Services]] (HHS)  | Health Scientist, Influenza Division; Biomedical Advanced Research and Development Authority  |
| [[Annaliesa Anderson]]  | [[pharmaceutical_companies:Pfizer]]  | Vice President and Chief Scientific Officer, Bacterial Vaccines  |
| [[James Anderson]]  | [[National Institutes of Health]] (NIH)  | Director, Division of Program Coordination, Planning, and Strategic Initiatives; Office of the Director  |
| [[Ralph Baric]]  | [[University of North Carolina]]  | Professor, Deptartment of Epidemiology and Deptartment of Microbiology and Immunology  |
| [[Kara Carter]]  | [[pharmaceutical_companies:Dewpoint Therapeutics]]  | Senior Vice President, Discovery Biology  |
| [[Marc Charette]]  | [[National Heart, Lung, and Blood Institute]]  | Program Director; Division of Cardiovascular Diseases  |
| [[Tomas Cihlar]]  | [[pharmaceutical_companies:Gilead Sciences]]  | Vice President and Head of Virology  |
| [[Christine Colvis]]  | [[National Center for Advancing Translational Sciences]]  | Director, Drug Development Partnership Programs  |
| [[Michael Diamond]]  | [[Washington University School of Medicine in St. Louis]]  | The Herbert S. Gasser Professor, Departments of Medicine, Molecular Microbiology, Pathology & Immunology  |
| [[Ken Duncan]]  | [[Bill & Melinda Gates Foundation]]  | Deputy Director, Discovery – Therapeutics  |
| [[Prabhavathi Fernandes]]  | [[National Biodefense Science Board]]  | SAC of GARDP, Chair  |
| [[Joshua Fessel]]  | [[National Heart, Lung, and Blood Institute]]  | Program Director, Lung Vascular Biology Program; Division of Lung Disease  |
| [[Clint Florence]]  | [[National Institute of Allergy and Infectious Diseases]] (NIAID)  | Program Officer, Research Resource Section, OBRR, DMID  |
| [[Greg Gatto]]  | [[RTI International]]  | Drug Development Regulatory Project Leader  |
| [[Jay Grobler]]  | [[pharmaceutical_companies:Merck]]  | Executive Director, Infectious Disease and Vaccines  |
| [[Nancy Haigwood]]  | [[Oregon National Primate Research Center]]; [[Oregon Health & Science University]]  | Director and Professor  |
| [[Judith Hewitt]]  | [[National Institute of Allergy and Infectious Diseases]] (NIAID)  | Deputy Director, Office of Biodefense, Research Resources and Translational Research  |
| [[Sheri Hild]]  | [[National Institutes of Health]] (NIH)  | Program Director for National Primate Research Centers; Office of Research and Infrastructure Program  |
| [[Samantha Jonson]]  | [[National Center for Advancing Translational Sciences]]  | Special Assistant to the Director  |
| [[Isis Kanevsky]]  | [[pharmaceutical_companies:Pfizer]]  | Director  |
| [[Kent Lloyd]]  | [[University of California, Davis]]  | Professor, Department of Surgery, School of Medicine Director, Mouse Biology Program; Associate Director, Comprehensive Cancer Center  |
| [[Joanne Lumsden]]  | [[National Center for Advancing Translational Sciences]]  | Senior Scientific Program Manager, Drug Development Partnership Programs  |
| [[Cat Lutz]]  | [[Jackson Laboratory]]  | Senior Director, Mouse Repository & In Vivo Pharmacology, Rare and Orphan Disease Center  |
| [[Stephen Mason]]  | [[pharmaceutical_companies:Pfizer]]  | Research Associate & Viral Drug Discovery Fellow  |
| [[Frank Nestle]]  | [[pharmaceutical_companies:Sanofi]]  | Global Head of Immunology Therapeutic Research Area and Chief Scientific Officer North America  |
| [[Elizabeth Ottinger]]  | [[National Center for Advancing Translational Sciences]]  | Senior Program Manager, Division of Preclinical Innovation  |
| [[David Payne]]  | [[pharmaceutical_companies:GlaxoSmithKline]]  | Vice President & Head, Medicine Opportunities Research Unit  |
| [[Louise Pitt]]  | [[United States Army Medical Research Institute of Infectious Diseases]]  | Director, Center for Aerobiological Sciences  |
| [[Antonello Punturieri]]  | [[National Heart, Lung, and Blood Institute]]  | Program Director, Division of Lung Diseases  |
| [[Srinivas Rao]]  | [[pharmaceutical_companies:Sanofi]]  | Global Head, Translational In Vivo Models Global Research Platform  |
| [[Jay Rappaport]]  | [[Tulane University National Primate Research Center]]  | Professor of Microbiology and Immunology; Director and Chief Academic Officer  |
| [[John Young]]  | [[pharmaceutical_companies:Roche]]  | Global Head Infectious Diseases and Vice President  |
| [[Roland Zahn]]  | [[pharmaceutical_companies:Janssen]]  | Senior Scientific Director; Head Preclinical Immunology, Viral Vaccines  |